Evidence map›Paper›PMID 25816232›Full record

ArticlePloS one2015

Intrapericardial administration of mesenchymal stem cells in a large animal model: a bio-distribution analysis.

Rebeca Blázquez, Francisco Miguel Sánchez-Margallo, Verónica Crisóstomo, Claudia Báez, Juan Maestre, Mónica García-Lindo, Alejandra Usón, Verónica Álvarez, Javier G Casado

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The Technique of Permanent Pericardial Catheter in Mice.JACC. Basic to translational science · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Anesthesia Protocols used to Create Ischemia Reperfusion Myocardial Infarcts in Swine.Journal of the American Association for Laboratory Animal Science : JAALAS · 2020
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Rebeca BlázquezStem Cell Therapy Unit, Minimally Invasive Surgery Centre, Caceres, Spain.
Francisco Miguel Sánchez-MargalloStem Cell Therapy Unit, Minimally Invasive Surgery Centre, Caceres, Spain.
Verónica CrisóstomoEndoluminal Therapy and Diagnosis, Minimally Invasive Surgery Centre, Caceres, Spain.
Claudia BáezEndoluminal Therapy and Diagnosis, Minimally Invasive Surgery Centre, Caceres, Spain.
Juan MaestreEndoluminal Therapy and Diagnosis, Minimally Invasive Surgery Centre, Caceres, Spain.
Mónica García-LindoAnaesthetics Unit, Minimally Invasive Surgery Centre, Caceres, Spain.
Alejandra UsónStem Cell Therapy Unit, Minimally Invasive Surgery Centre, Caceres, Spain.
Verónica ÁlvarezStem Cell Therapy Unit, Minimally Invasive Surgery Centre, Caceres, Spain.
Javier G CasadoStem Cell Therapy Unit, Minimally Invasive Surgery Centre, Caceres, Spain.
Centro de Cirugía de Mínima Invasión Jesús Usón · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The appropriate administration route for cardiovascular cell therapy is essential to ensure the viability, proliferative potential, homing capacity and implantation of transferred cells. At the present, the intrapericardial administration of pharmacological agents is considered an efficient method for the treatment of cardiovascular diseases. However, only a few reports have addressed the question whether the intrapericardial delivery of Mesenchymal Stem Cells (MSCs) could be an optimal administration route. This work firstly aimed to analyze the pericardial fluid as a cell-delivery vehicle. Moreover, the in vivo biodistribution pattern of intrapericardially administered MSCs was evaluated in a clinically relevant large animal model. Our in vitro results firstly showed that, MSCs viability, proliferative behavior and phenotypic profile were unaffected by exposure to pericardial fluid. Secondly, in vivo cell tracking by magnetic resonance imaging, histological examination and Y-chromosome amplification clearly demonstrated the presence of MSCs in pericardium, ventricles (left and right) and atrium (left and right) when MSCs were administered into the pericardial space. In conclusion, here we demonstrate that pericardial fluid is a suitable vehicle for MSCs and intrapericardial route provides an optimal retention and implantation of MSCs.

Indexed as

AnimalsCell ProliferationCells, CulturedCell SurvivalCell TrackingMagnetic Resonance ImagingMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationModels, AnimalPericardial FluidSwineTissue Distribution

Identifiers

PMID25816232
PMCPMC4376786
OpenAlexW2006408578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.